Related Experiment Video

Updated: Jun 23, 2025

Isolation of Atrial Myocytes from Adult Mice
08:34

Isolation of Atrial Myocytes from Adult Mice

Published on: July 25, 2019

10.4K

Management of Arrhythmias and Conduction Disorders in Amyloid Cardiomyopathy

Katarzyna Holcman1,2, Andrzej Ząbek3, Krzysztof Boczar3

  • 1Department of Nuclear Medicine, John Paul II Hospital, 31-202 Krakow, Poland.

Journal of Clinical Medicine
|June 19, 2024
PubMed

Insights

Cardiac amyloidosis increases arrhythmia risk. Management strategies for atrial and ventricular arrhythmias, including anticoagulation and device therapy, require individualized approaches for better patient outcomes.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Cardiovascular Medicine

Background:

  • Cardiac amyloidosis involves abnormal protein deposits in the heart, causing restrictive cardiomyopathy.
  • This condition significantly elevates the risk of cardiac arrhythmias and conduction disturbances.
  • Understanding these complications is crucial for effective patient management.

Purpose of the Study:

  • To review current knowledge on cardiac complications of amyloidosis.
  • To discuss contemporary management strategies for atrial and ventricular arrhythmias.
  • To highlight recent advancements and ongoing clinical challenges in the field.

Main Methods:

  • Literature review of current understanding and management strategies.
  • Examination of prevalence and impact of atrial arrhythmias, including atrial fibrillation.
  • Analysis of treatment options for ventricular arrhythmias and device therapy.

Main Results:

  • Atrial fibrillation is common, necessitating stroke risk assessment and anticoagulation.
  • Rate and rhythm control present challenges, with varying efficacy of drugs and ablation.
  • Implantable cardioverter-defibrillators for ventricular arrhythmias remain a subject of debate.

Conclusions:

  • Individualized treatment plans are essential for cardiac amyloidosis patients.
  • Refining management strategies requires ongoing research and clinical exploration.
  • Improving outcomes necessitates a tailored approach to complex cardiac complications.

Keywords:
ALATTRamyloid cardiomyopathyamyloidosis

More Related Videos

Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice08:05

Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice

Published on: June 29, 2022

2.7K
Microelectrode Array Recording of Sinoatrial Node Firing Rate to Identify Intrinsic Cardiac Pacemaking Defects in Mice09:20

Microelectrode Array Recording of Sinoatrial Node Firing Rate to Identify Intrinsic Cardiac Pacemaking Defects in Mice

Published on: July 5, 2021

3.0K

Related Concept Videos

Disturbances in Heart Rhythm01:28

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
933
Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
910
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.3K
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
735
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
564
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
968